A Systematic Review and Statistical Analysis of Factors Influencing the Cost-Effectiveness of Transcatheter Aortic Valve Implantation for Symptomatic Severe Aortic Stenosis

References

• Carabello BA, Paulus WJ. Aortic stenosis. Lancet. 2009;373(9667):956–966. doi:10.1016/S0140-6736(09)60211-7
   PubMed Web of Science ®Google Scholar
• Joseph J, Naqvi SY, Giri J, et al. Aortic Stenosis: pathophysiology, Diagnosis, and Therapy. Am J Med. 2017;130(3):253–263. doi:10.1016/j.amjmed.2016.10.005
   PubMed Web of Science ®Google Scholar
• Dweck MR, Boon NA, Newby DE. Calcific Aortic Stenosis. J Am Coll Cardiol. 2012;60(19):1854–1863. doi:10.1016/j.jacc.2012.02.093
   PubMed Web of Science ®Google Scholar
• Bates ER. Treatment options in severe aortic stenosis. Circulation. 2011;124(3):355–359. doi:10.1161/CIRCULATIONAHA.110.974204
   PubMed Web of Science ®Google Scholar
• Turina J, Hess O, Sepulcri F, et al. Spontaneous course of aortic valve disease. Eur Heart J. 1987;8(5):471–483. doi:10.1093/oxfordjournals.eurheartj.a062307
   PubMed Web of Science ®Google Scholar
• Schwarz F, Baumann P, Manthey J, et al. The effect of aortic valve replacement on survival. Circulation. 1982;66(5):1105–1110. doi:10.1161/01.CIR.66.5.1105
   PubMed Web of Science ®Google Scholar
• Ramlawi B, Ramchandani M, Reardon MJ. Surgical Approaches to Aortic Valve Replacement and Repair—Insights and Challenges. Int Cardiol Rev. 2014;9(1):32.
   PubMedGoogle Scholar
• Marquis-Gravel G, Redfors B, Leon MB, et al. Medical treatment of aortic stenosis. Circulation. 2016;134(22):1766–1784. doi:10.1161/CIRCULATIONAHA.116.023997
   PubMed Web of Science ®Google Scholar
• Cribier A. Development of transcatheter aortic valve implantation (TAVI): a 20-year odyssey. Arch Cardiovasc Dis. 2012;105(3):146–152. doi:10.1016/j.acvd.2012.01.005
   PubMed Web of Science ®Google Scholar
• Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106(24):3006–3008. doi:10.1161/01.CIR.0000047200.36165.B8
   PubMed Web of Science ®Google Scholar
• Clayton B, Morgan-Hughes G, Roobottom C. Transcatheter aortic valve insertion (TAVI): a review. Br J Radiol. 2014;87(1033):1033. doi:10.1259/bjr.20130595
   Web of Science ®Google Scholar
• Biasco L, Ferrari E, Pedrazzini G, et al. Access Sites for TAVI: patient Selection Criteria, Technical Aspects, and Outcomes. Front Cardiovascular Med. 2018;5:88. doi:10.3389/fcvm.2018.00088
   PubMed Web of Science ®Google Scholar
• Branny M, Branny P, Hudec M, et al. Alternative Access Routes for Transcatheter Aortic Valve Implantation (TAVI). Cor et Vasa. 2017;59(1):e10e16.
   Google Scholar
• Walther T, Simon P, Dewey T, et al. Transapical Minimally Invasive Aortic Valve Implantation. Circulation. 2007;116(11):653. doi:10.1161/CIRCULATIONAHA.106.677237
   Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack M, et al. Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery. N Eng J Med. 2010;363(17):1597–1607. doi:10.1056/NEJMoa1008232
   PubMed Web of Science ®Google Scholar
• Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients. n Engl j Med. 2011;364:2187–2198. doi:10.1056/NEJMoa1103510
   PubMed Web of Science ®Google Scholar
• Lanz J, Kim W-K, Walther T, et al. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial. Lancet. 2019;394(10209):1619–1628. doi:10.1016/S0140-6736(19)32220-2
   PubMed Web of Science ®Google Scholar
• Makkar RR, Cheng W, Waksman R, et al. Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial. Lancet. 2020;396(10252):669–683. doi:10.1016/S0140-6736(20)31358-1
   PubMed Web of Science ®Google Scholar
• Thiele H, Kurz T, Feistritzer H-J, et al. Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial. Eur Heart J. 2020;41(20):1890–1899. doi:10.1093/eurheartj/ehaa036
   PubMed Web of Science ®Google Scholar
• Feistritzer H-J, Kurz T, Stachel G, et al. Impact of anesthesia strategy and valve type on clinical outcomes after transcatheter aortic valve replacement. J Am Coll Cardiol. 2021;77(17):2204–2215. doi:10.1016/j.jacc.2021.03.007
   PubMed Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack MJ, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Eng J Med. 2016;374(17):1609–1620. doi:10.1056/NEJMoa1514616
   PubMed Web of Science ®Google Scholar
• Mack MJ, Leon MB, Thourani VH, et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Eng J Med. 2019;380(18):1695–1705. doi:10.1056/NEJMoa1814052
   PubMed Web of Science ®Google Scholar
• Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387(10034):2218–2225. doi:10.1016/S0140-6736(16)30073-3
   PubMed Web of Science ®Google Scholar
• Stachel G, Abdel-Wahab M, De waha-thiele S, et al. Paravalvular Regurgitation According to Transcatheter Aortic Valve Prosthesis Type: insights From the Randomized SOLVE-TAVI Trial. Cardiovascular Imaging. 2021;14(6):1277–1279. doi:10.1016/j.jcmg.2020.10.025
   Google Scholar
• Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Eng J Med. 2017;376(14):1321–1331. doi:10.1056/NEJMoa1700456
   PubMed Web of Science ®Google Scholar
• Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Eng J Med. 2019;380(18):1706–1715. doi:10.1056/NEJMoa1816885
   PubMed Web of Science ®Google Scholar
• Genereux P, Head SJ, Wood DA, et al. Transcatheter aortic valve implantation 10-year anniversary: review of current evidence and clinical implications. Eur Heart J. 2012;33(19):2388–2398. doi:10.1093/eurheartj/ehs220
   PubMed Web of Science ®Google Scholar
• Kahlert P, Knipp SC, Schlamann M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation. 2010;121(7):870–878. doi:10.1161/CIRCULATIONAHA.109.855866
   PubMed Web of Science ®Google Scholar
• Siontis GCM, Jüni P, Pilgrim T, et al. Predictors of Permanent Pacemaker Implantation in Patients With Severe Aortic Stenosis Undergoing TAVR: a Meta-Analysis. J Am Coll Cardiol. 2014;64(2):129–140. doi:10.1016/j.jacc.2014.04.033
   PubMed Web of Science ®Google Scholar
• Writing Committee M, Otto CM, Nishimura RA, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: executive Summary: a Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;77(4):450–500. doi:10.1016/j.jacc.2020.11.035
   PubMed Web of Science ®Google Scholar
• Vahanian A, Beyersdorf F, Praz F. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur j Cardio Thoracic Surg. 2021;60(4):727–800. doi:10.1093/ejcts/ezab389
   PubMed Web of Science ®Google Scholar
• Authority, H.I.a.Q. Health Technology Assessment of Transcatheter Aortic Valve Implantation (TAVI) in Patients with Severe Symptomatic Aortic Stenosis at Low and Intermediate Risk of Surgical Complications; 2019.
   Google Scholar
• Health Quality O. Transcatheter Aortic Valve Implantation for Treatment of Aortic Valve Stenosis: a Health Technology Assessment. Ont Health Technol Assess Ser. 2016;16(19):1–94.
   Google Scholar
• Group, H.I.S.a.t.S.H.T. Transcatheter Aortic Valve Implantation (TAVI) for the Treatment of Patients with Severe Symptomatic Aortic Stenosis Who are at Intermediate Surgical Risk; 2019.
   Google Scholar
• Sante, H.A.D. SAPIEN 3: Traitement de la sténose aortique sévère symptomatique en France chez les patients à faible risque chirurgical; 2021.
   Google Scholar
• Committee, M.S.A. Public Summary Document: Application No. 1361.2: Transcatheter Aortic Valve Implantation via Transfemoral Delivery. Canberra (ACT): Medical Services Advisory Committee; 2016.
   Google Scholar
• Himmels JP, Flottorp SA, Stoinska-Schneider AK, et al. Transcatheter Aortic Valve Implantation (TAVI) versus Surgical Aortic Valve Replacement (SAVR) for Patients with Severe Aortic Stenosis and Low Surgical Risk and Across Surgical Risk Groups: A Health Technology Assessment. Heart Lung Circulation. 2021;30:1918.
   PubMed Web of Science ®Google Scholar
• Eaton J, Mealing S, Thompson J, et al. Is transcatheter aortic valve implantation (TAVI) a cost-effective treatment in patients who are ineligible for surgical aortic valve replacement? A systematic review of economic evaluations. J Med Econ. 2014;17(5):365–375. doi:10.3111/13696998.2014.903256
   PubMedGoogle Scholar
• Gialama F, Prezerakos P, Apostolopoulos V, et al. Systematic review of the cost-effectiveness of transcatheter interventions for valvular heart disease. Eur Heart J Quality Care Clin Outcomes. 2018;4(2):81–90. doi:10.1093/ehjqcco/qcx049
   PubMed Web of Science ®Google Scholar
• Indraratna P, Ang SC, Gada H, et al. Systematic review of the cost-effectiveness of transcatheter aortic valve implantation. J Thoracic Cardiovascular Surg. 2014;148(2):509–514. doi:10.1016/j.jtcvs.2013.10.023
   PubMed Web of Science ®Google Scholar
• Shields GE, Elvidge J. Challenges in synthesising cost-effectiveness estimates. Syst Rev. 2020;9(1):1–7. doi:10.1186/s13643-020-01536-x
   PubMed Web of Science ®Google Scholar
• Friedman J, Hastie T, Tibshirani R. The Elements of Statistical Learning. New York: Springer series in statistics; 2001.
   Google Scholar
• Watt M, Mealing S, Eaton J, et al. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart. 2012;98(5):370–376. doi:10.1136/heartjnl-2011-300444
   PubMed Web of Science ®Google Scholar
• Sehatzadeh S, Doble B, Xie F, et al. Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence-based Analysis (part B). Ont Health Technol Assess Ser. 2012;12(14):1–62.
   Google Scholar
• Reynolds MR, Magnuson EA, Lei Y, et al. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol. 2012;60(25):2683–2692. doi:10.1016/j.jacc.2012.09.018
   PubMed Web of Science ®Google Scholar
• Doble B, Blackhouse G, Goeree R, et al. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective. J Thoracic Cardiovascul Surg. 2013;146(1):52–60.e53. doi:10.1016/j.jtcvs.2012.06.018
   PubMed Web of Science ®Google Scholar
• Hancock-Howard RL, Feindel CM, Rodes-Cabau J, et al. Cost effectiveness of transcatheter aortic valve replacement compared to medical management in inoperable patients with severe aortic stenosis: canadian analysis based on the PARTNER Trial Cohort B findings. J Med Econ. 2013;16(4):566–574. doi:10.3111/13696998.2013.770747
   PubMedGoogle Scholar
• Murphy A, Fenwick E, Toff WD, et al. Transcatheter aortic valve implantation for severe aortic stenosis: the cost-effectiveness case for inoperable patients in the United Kingdom. Int J Technol Assess Health Care. 2013;29(1):12–19. doi:10.1017/S0266462312000670
   PubMed Web of Science ®Google Scholar
• Simons CT, Cipriano LE, Shah RU, et al. Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis. Circulation. Cardiovascular Qual Outcomes. 2013;6(4):419–428. doi:10.1161/CIRCOUTCOMES.113.000280
   PubMed Web of Science ®Google Scholar
• Brecker S, Mealing S, Padhiar A, et al. Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study. Open Heart. 2014;1(1):e000155. doi:10.1136/openhrt-2014-000155
   PubMedGoogle Scholar
• Sante HAD. Système Medtronic Corevalve; 2017.
   Google Scholar
• Kodera S, Kiyosue A, Ando J, et al. Cost effectiveness of transcatheter aortic valve implantation in patients with aortic stenosis in Japan. J Cardiol. 2018;71(3):223–229. doi:10.1016/j.jjcc.2017.10.008
   PubMed Web of Science ®Google Scholar
• Inoue S, Nakao K, Hanyu M, et al. Cost-effectiveness of transcatheter aortic valve implantation using a balloon-expandable valve in Japan: experience From the Japanese pilot health technology assessment. Value Health Reg Issues. 2020;21:82–90. doi:10.1016/j.vhri.2019.07.013
   PubMedGoogle Scholar
• Lorenzoni V, Barbieri G, Saia F, et al. The cost-effectiveness of transcatheter aortic valve implantation: exploring the Italian National Health System perspective and different patient risk groups. Eur J Health Econ. 2021;21:21.
   Google Scholar
• Pinar E, Hurtado J, Robles M, et al. Cost-effectiveness analysis of the SAPIEN 3 transcatheter aortic valve implant in patients with symptomatic severe aortic stenosis. Rev Esp Cardiol. 2021;17:17.
   Google Scholar
• Gada H, Agarwal S, Marwick TH. Perspective on the cost-effectiveness of transapical aortic valve implantation in high-risk patients: outcomes of a decision-analytic model. Ann Cardiothorac Surg. 2012;1(2):145–155. doi:10.3978/j.issn.2225-319X.2012.06.12
   PubMedGoogle Scholar
• Gada H, Kapadia SR, Tuzcu EM, et al. Markov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patients. Am J Card. 2012;109(9):1326–1333. doi:10.1016/j.amjcard.2011.12.030
   PubMed Web of Science ®Google Scholar
• Fairbairn TA, Meads DM, Hulme C, et al. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk. Heart. 2013;99(13):914–920. doi:10.1136/heartjnl-2013-303722
   PubMed Web of Science ®Google Scholar
• Bayón J, Gutiérrez Iglesias A, Mateos Del Pino M, et al. Análisis coste-efectividad del recambio valvular aórtico mediante prótesis valvular percutánea frente al tratamiento quirúrgico habitual. Ministerio de Sanidad, Servicios Sociales e Igualdad; Servicio de Evaluación de Tecnologías Sanitarias del País Vasco. Informes de Evaluación de Tecnologías Sanitarias: OSTEBA; 2014.
   Google Scholar
• Reynolds MR, Lei Y, Wang K, et al. Cost-effectiveness of transcatheter aortic valve replacement with a self-expanding prosthesis versus surgical aortic valve replacement. J Am Coll Cardiol. 2016;67(1):29–38. doi:10.1016/j.jacc.2015.10.046
   PubMed Web of Science ®Google Scholar
• Geisler BP, Huygens SA, Reardon MJ, et al. Cost-effectiveness and projected survival of self-expanding transcatheter versus surgical aortic valve replacement for high risk patients in a european setting: a dutch analysis based on the corevalve high risk trial. Structural Heart. 2017;1(5–6):267–274. doi:10.1080/24748706.2017.1381357
   Google Scholar
• Tarride JE, Luong T, Goodall G, et al. A Canadian cost-effectiveness analysis of SAPIEN 3 transcatheter aortic valve implantation compared with surgery, in intermediate and high-risk severe aortic stenosis patients. Clinicoecon Outcomes Res. 2019;11:477–486. doi:10.2147/CEOR.S208107
   PubMed Web of Science ®Google Scholar
• Ferreira-Gonzalez I, You JJ, Karanicolas PJ, et al. Evidence of the cost-effectiveness of Edwards Sapien transcatheter aortic valve implantation (TAVI) in high-risk patients with symptomatic aortic stenosis in Spain: preliminary results. Pharmacoeconomics. 2013;10(1):1–13. Spanish.
   Google Scholar
• Orlando R, Pennant M, Rooney S, et al. Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation. Health Technol Asses. 2013;17(33):1–86. doi:10.3310/hta17330
   PubMed Web of Science ®Google Scholar
• Tam DY, Hughes A, Fremes SE, et al. A cost-utility analysis of transcatheter versus surgical aortic valve replacement for the treatment of aortic stenosis in the population with intermediate surgical risk. J Thoracic Cardiovascul Surg. 2018;155(5):1978–1988.e1971. doi:10.1016/j.jtcvs.2017.11.112
   PubMed Web of Science ®Google Scholar
• Tam DY, Hughes A, Wijeysundera HC, et al. Cost-effectiveness of self-expandable transcatheter aortic valves in intermediate-risk patients. Ann Thorac Surg. 2018;106(3):676–683. doi:10.1016/j.athoracsur.2018.03.069
   PubMed Web of Science ®Google Scholar
• Baron SJ, Wang K, House JA, et al. Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk. Circulation. 2019;139(7):877–888. doi:10.1161/CIRCULATIONAHA.118.035236
   PubMed Web of Science ®Google Scholar
• Goodall G, Lamotte M, Ramos M, et al. Cost-effectiveness analysis of the SAPIEN 3 TAVI valve compared with surgery in intermediate-risk patients. J Med Econ. 2019;22(4):289–296. doi:10.1080/13696998.2018.1559600
   PubMed Web of Science ®Google Scholar
• Fagerlund BC, Stoinska-Schneider A, Lauvrak V, et al. Health technology assessment of Transcatether aortic valve implantation (TAVI) as treatment of patients with severe aortic stenosis and intermediate surgical risk–Part 2. Health Economic Evaluat. 2019.
   Google Scholar
• Zhou J, Liew D, Duffy SJ, et al. Cost-effectiveness of transcatheter aortic valve implantation compared to surgical aortic valve replacement in the intermediate surgical risk population. Int J Cardiol. 2019;294:17–22. doi:10.1016/j.ijcard.2019.06.057
   PubMed Web of Science ®Google Scholar
• Wales HT. Evidence appraisal report: transcatheter aortic valve implantation to treat people with severe symptomatic aortic stenosis, who are at intermediate surgical risk; 2020.
   Google Scholar
• Geisler BP, Jørgensen TH, Thyregod HGH, et al. Cost-effectiveness of transcatheter versus surgical aortic valve replacement in patients at lower surgical risk: results from the NOTION trial. Eurointervention. 2019;15(11):e959–e967. doi:10.4244/EIJ-D-18-00847
   PubMed Web of Science ®Google Scholar
• Tam DY, Azizi PM, Fremes SE, et al. The cost-effectiveness of transcatheter aortic valve replacement in low surgical risk patients with severe aortic stenosis. Eur Heart J Qual Care Clin Outcomes. 2020;09:09.
   Google Scholar
• Gilard M, Eltchaninoff H, Iung B, et al. Cost-effectiveness analysis of sapien 3 transcatheter aortic valve implantation procedure compared with surgery in patients with severe aortic stenosis at low risk of surgical mortality in France. Value Health. 2021;25(4):605–613. doi:10.1016/j.jval.2021.10.003
   PubMed Web of Science ®Google Scholar
• Sante HAD. Medtronic CoreValve Evolut R et Evolut PRO: traitement de la sténose aortique sévère symptomatique en France chez les patients à faible risque chirurgical; 2021.
   Google Scholar
• Zhou JY, Liew D, Duffy SJ, et al. Cost-effectiveness of transcatheter versus surgical aortic valve replacement in low-risk patients with severe aortic stenosis. Heart Lung Circ. 2021;30(4):547–554. doi:10.1016/j.hlc.2020.09.934
   PubMed Web of Science ®Google Scholar
• Kuntjoro I, Tay E, Hon J, et al. Cost-effectiveness of transcatheter aortic valve implantation in intermediate and low risk severe aortic stenosis patients in Singapore. Ann Acad Med Singapore. 2020;49(7):423–433. doi:10.47102/annals-acadmedsg.2019198
   PubMed Web of Science ®Google Scholar
• Reynolds MR, Baron SJ, Cohen DJ. Economic Implications of Transcatheter Aortic Valve Replacement in Patients at Intermediate Surgical Risk. Circulation. 2016;134(19):1416–1418. doi:10.1161/CIRCULATIONAHA.116.021962
   PubMed Web of Science ®Google Scholar
• Reynolds MR, Magnuson EA, Wang K, et al. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B). Circulation. 2012;125(9):1102–1109. doi:10.1161/CIRCULATIONAHA.111.054072
   PubMed Web of Science ®Google Scholar
• Baron SJ, Wang K, Arnold SV, et al. Cost-Effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients with Heart Failure and Secondary Mitral Regurgitation: results from the COAPT Trial. Circulation. 2019;140(23):1881–1891. doi:10.1161/CIRCULATIONAHA.119.043275
   PubMed Web of Science ®Google Scholar
• Young C, Horton J. Transcatheter Aortic Valve Implantation for Patients with Severe Symptomatic Aortic Stenosis. Canadian J Health Technol. 2021;1(7). doi:10.51731/cjht.2021.100
   Google Scholar
• Chotnoppharatphatthara P, Yoodee V, Taesotikul S, et al. Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis: systematic review of cost-effectiveness analysis. Eur J Health Economics. 2022;1–18.
   Web of Science ®Google Scholar
• Auffret V, Lefevre T, Van Belle E, et al. Temporal trends in transcatheter aortic valve replacement in France: France 2 to France TAVI. J Am Coll Cardiol. 2017;70(1):42–55. doi:10.1016/j.jacc.2017.04.053
   PubMed Web of Science ®Google Scholar